Search clinical trials for: febuxostat

Total 96 results

Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults

Gout With Hyperuricemia in Adults
Bio-innova Co., Ltd

Not yet recruiting

Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults

Gout With Hyperuricemia in Adults
JW Pharmaceutical

Recruiting

A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients (EPIC)

Gout

Korea, Republic of
Tanta University

Recruiting

Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia

Hyperuricemia | Non Alcoholic Steatohepatitis

Egypt
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Primary Gout and Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults

Primary Gout With Hyperuricemia in Adults
The Affiliated Hospital of Qingdao University

Recruiting

To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout

Gout

China
University Hospital, Rouen

Not yet recruiting

Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration (FEFACRIGOU)

Gout
Assiut University

Not yet recruiting

Hyperuricemia and Diabetic Nephropathy

Diabetic Nephropathies | Hyperuricemia
Ningbo No. 1 Hospital

Not yet recruiting

Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout

Nonalcoholic Fatty Liver Disease

China
Assistance Publique - Hôpitaux de Paris

Recruiting

Treat-to-target by Email During Urate-lowering Therapy in Gout (GOUTEmail)

Hyperuricemia | Gout | Inflammatory Rheumatism | Posology Adjustment

France
Peking University Third Hospital

Recruiting

The Influence of Urate-lowering Therapy on Sperm Quality of Male Gouty Patients：A Prospective Cohort Study (INITIAL)

Gout

China
Landspitali University Hospital
Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases...

Completed

Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion

Adenine Phosphoribosyltransferase Deficiency

Iceland
VA Office of Research and Development

Completed

CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat

Chronic Kidney Diseases | Gout

United States
Maastricht University
Netherlands Brain Foundation

Completed

Roflumilast to Treat Cognitive Sequela After Stroke (ROSTMEMA)

Cerebrovascular Disorders | Functional Recovery | Memory | Drug Intervention

Netherlands
National Taiwan University Hospital
National Taiwan University Hospital, Yun-Lin Branch

Terminated

Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout

Gout

Taiwan
Eisai Co., Ltd.

Completed

A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

Gout

China
Ain Shams University

Completed

Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

Hyperuricemia | Non-Alcoholic Fatty Liver Disease

Egypt
Washington University School of Medicine

Active, not recruiting

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Glioblastoma Multiforme

United States
University of Texas Southwestern Medical Center

Completed

Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome

Gout

United States
Seoul National University Hospital

Completed

A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Febuxostat on the Pharmacokinetics of Methotrexate in Healthy Subjects

Drug Interaction

Korea, Republic of
Medical Practice Prof D. Ivanov

Enrolling by invitation

The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) (IMPULsKF)

Gout | CKD Stage 1-4 | SUA Level (>8 mg/dL; 480 µmol/L)

Ukraine
TWi Biotechnology, Inc.

Completed

A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout

Gout

Taiwan
Ain Shams University

Completed

Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3

Contrast-induced Nephropathy | Chronic Kidney Disease stage3

Egypt
Ironwood Pharmaceuticals, Inc.
Medpace, Inc.

Terminated

A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment

Gout | Chronic Kidney Disease (CKD)

United States, Hungary, Poland, Czechia
Menarini Group

Terminated

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults (FLORET)

Tumor Lysis Syndrome

Spain, Hungary, Italy, Bulgaria
Takeda

Completed

Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information

Cardiovascular Diseases | Gout

United States
Arthrosi Therapeutics

Completed

Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients

Gout Patients

New Zealand
Arthrosi Therapeutics

Completed

The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males

Healthy Volunteers

Australia
Sun Yat-sen University

Unknown

Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients (LUMINA)

Hyperuricemia

China
Xuhui Central Hospital, Shanghai

Unknown

A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis.

Urolithiasis | Hypouricemia, Renal

China
National Defense Medical Center, Taiwan

Unknown

Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction

Metabolic Syndrome | Hyperuricemia | Left Ventricular Diastolic Dysfunction

Taiwan
Ai Peng

Unknown

Role of Uralyt-U in Patients With Hyperuricemia

Hyperuricemia | Uric Acid Stones

China
Erasme University Hospital
Fonds National de la Recherche Scientifique; Fonds Erasme

Completed

Uric Acid Effects on Endothelium and Oxydative Stress

Hypertension | Oxidative Stress | Cardiovascular System | Endothelial Function

Belgium
AstraZeneca

Completed

Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria

Type 2 Diabetes | Albuminuria | Hyperuricemia

United States
University of California, San Diego

Completed

Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure

Hypertension | Prehypertension | Gout | Pulse Wave Velocity | 24 Hour Blood Pressure

United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia

Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia

Hyperuricemia

China
Guang'anmen Hospital of China Academy of Chinese...
The Second Affiliated Hospital of Dalian Medical University; Shenzhen Traditional...

Unknown

Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

Gout Flare

China
AstraZeneca
Contract Research Organization: USA; PAREXEL Early Phase Clinical Unit Baltimore and other collaborators

Completed

A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

Asymptomatic Hyperuricemia

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout

Gout

China
University of South Florida
Takeda Pharmaceuticals North America, Inc.

Completed

An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.

Gout

United States
Getz Pharma

Completed

Zurig (Febuxostat) 40mg Efficacy and Safety Trial (ZEST)

Hyperuricemia

Pakistan
Shanghai 10th People's Hospital

Completed

Compare the Renal Protective Effects of Febuxostat and Benzbromarone

Chronic Kidney Disease | Hyperuricemia | Abnormal Renal Function

China
Shanghai 10th People's Hospital

Completed

The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients

Hyperuricemia | Disorders Associated With Peritoneal Dialysis

China
Pharmtechnology LLC
Altasciences Company, Inc.

Completed

Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

Bioequivalence

Canada
Menarini International Operations Luxembourg SA

Completed

Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout (FORWARD)

Gout

Poland, Serbia, Germany, Italy, Netherlands, Romania
Instituto Nacional de Cardiologia Ignacio Chavez
Salvador López Gil; Armando Vázquez Rangel

Unknown

Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI) (CI-AKI)

Contrast-induced Nephropathy | Contrast-induced Acute Kidney Injury

Mexico
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan

Search clinical trials for: febuxostat

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations